Published in Acta Oncol on November 28, 2013
The influence of dose heterogeneity on tumour control probability in fractionated radiation therapy. Phys Med Biol (2011) 2.36
Prostate alpha/beta revisited -- an analysis of clinical results from 14 168 patients. Acta Oncol (2012) 1.31
Stricture of the proximal esophagus in head and neck carcinoma patients after radiotherapy. Cancer (2003) 1.28
A model for the relative biological effectiveness of protons: the tissue specific parameter α/β of photons is a predictor for the sensitivity to LET changes. Acta Oncol (2012) 1.03
Is the α/β ratio for prostate tumours really low and does it vary with the level of risk at diagnosis? Anticancer Res (2013) 1.02
Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone. Acta Oncol (2004) 0.94
Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures. Phys Med Biol (2007) 0.93
Dose-response relations for anal sphincter regarding fecal leakage and blood or phlegm in stools after radiotherapy for prostate cancer. Radiobiological study of 65 consecutive patients. Strahlenther Onkol (2005) 0.91
Determination and clinical verification of dose-response parameters for esophageal stricture from head and neck radiotherapy. Acta Oncol (2003) 0.90
Three-dimensional atlas of lymph node topography based on the visible human data set. Anat Rec B New Anat (2006) 0.90
Reply to the comment on 'The influence of dose heterogeneity on tumour control probability in fractionated radiation therapy'. Phys Med Biol (2013) 0.88
Depth absorbed dose and LET distributions of therapeutic 1H, 4He, 7Li, and 12C beams. Med Phys (2007) 0.87
The impact of different dose-response parameters on biologically optimized IMRT in breast cancer. Phys Med Biol (2008) 0.86
Biological effective dose evaluation and assessment of rectal and bladder complications for cervical cancer treated with radiotherapy and surgery. J Contemp Brachytherapy (2012) 0.86
Impact of variable RBE on proton fractionation. Med Phys (2013) 0.85
NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy. Phys Med Biol (2007) 0.85
Comments on 'Reconsidering the definition of a dose-volume histogram'--dose-mass histogram (DMH) versus dose-volume histogram (DVH) for predicting radiation-induced pneumonitis. Phys Med Biol (2006) 0.85
Effects of positioning uncertainty and breathing on dose delivery and radiation pneumonitis prediction in breast cancer. Acta Oncol (2002) 0.84
Esophageal stricture after radiotherapy in patients with head and neck cancer: experience of a single institution over 2 treatment periods. Head Neck (2010) 0.81
Comparison of the helical tomotherapy and MLC-based IMRT radiation modalities in treating brain and cranio-spinal tumors. Technol Cancer Res Treat (2009) 0.81
Variation in radiation sensitivity and repair kinetics in different parts of the spinal cord. Acta Oncol (2008) 0.81
Design of a fast multileaf collimator for radiobiological optimized IMRT with scanned beams of photons, electrons, and light ions. Med Phys (2007) 0.80
Prognostic significance of intratumour microvessel density and haemoglobin level in carcinoma of the uterine cervix. Acta Oncol (2002) 0.80
Survival and tumour control probability in tumours with heterogeneous oxygenation: a comparison between the linear-quadratic and the universal survival curve models for high doses. Acta Oncol (2014) 0.80
Dose-response relations for stricture in the proximal oesophagus from head and neck radiotherapy. Radiother Oncol (2010) 0.79
Investigation of the dose- and time-dependence of the induction of different types of cell death in a small‑cell lung cancer cell line: Implementation of the repairable-conditionally repairable model. Int J Oncol (2013) 0.79
Dosimetric comparison between intra-cavitary breast brachytherapy techniques for accelerated partial breast irradiation and a novel stereotactic radiotherapy device for breast cancer: GammaPod™. Phys Med Biol (2013) 0.78
Prediction of AVM obliteration after stereotactic radiotherapy using radiobiological modelling. Phys Med Biol (2002) 0.78
A systems biology approach to radiation therapy optimization. Radiat Environ Biophys (2010) 0.78
Treatment fractionation for stereotactic radiotherapy of lung tumours: a modelling study of the influence of chronic and acute hypoxia on tumour control probability. Radiat Oncol (2014) 0.77
Comparison of dose response models for predicting normal tissue complications from cancer radiotherapy: application in rat spinal cord. Cancers (Basel) (2011) 0.77
Toolkit for determination of dose-response relations, validation of radiobiological parameters and treatment plan optimization based on radiobiological measures. Technol Cancer Res Treat (2010) 0.77
Statistical methods for clinical verification of dose-response parameters related to esophageal stricture and AVM obliteration from radiotherapy. Phys Med Biol (2004) 0.77
A Monte Carlo program for the analysis of low-energy electron tracks in liquid water. Phys Med Biol (2011) 0.77
Variability in target delineation for cavernous sinus meningioma and anaplastic astrocytoma in stereotactic radiosurgery with Leksell Gamma Knife Perfexion. Acta Neurochir (Wien) (2014) 0.77
Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy. Phys Med Biol (2005) 0.77
Fractionated SRT using VMAT and Gamma Knife for brain metastases and gliomas - a planning study. J Appl Clin Med Phys (2015) 0.77
Interpretation of the dosimetric results of three uniformity regularization methods in terms of expected treatment outcome. Med Phys (2008) 0.77
Limitations (and merits) of PENELOPE as a track-structure code. Int J Radiat Biol (2011) 0.76
Will haptic feedback speed up medical imaging? An application to radiation treatment planning. Acta Oncol (2008) 0.76
Dose-response relationships for an atomized symptom of fecal incontinence after gynecological radiotherapy. Acta Oncol (2012) 0.76
Clinical and radiobiological advantages of single-dose stereotactic light-ion radiation therapy for large intracranial arteriovenous malformations. Technical note. J Neurosurg (2009) 0.75
In response to 'Behind EUD'. Acta Oncol (2009) 0.75
Radial secondary electron dose profiles and biological effects in light-ion beams based on analytical and Monte Carlo calculations using distorted wave cross sections. Radiat Res (2008) 0.75
Clinical validation of the LKB model and parameter sets for predicting radiation-induced pneumonitis from breast cancer radiotherapy. Phys Med Biol (2006) 0.75
Dosimetric evaluation of manually and inversely optimized treatment planning for high dose rate brachytherapy of cervical cancer. Acta Oncol (2014) 0.75
Evaluation of nuclear reaction cross-sections and fragment yields in carbon beams using the SHIELD-HIT Monte Carlo code. Comparison with experiments. Phys Med Biol (2012) 0.75
Radiation transport calculations for 50 MV photon therapy beam using the Monte Carlo code GEANT4. Radiat Prot Dosimetry (2005) 0.75
D, an effective uniform dose linked to the probability of response. Phys Med Biol (2002) 0.75
The dose--response relation for rat spinal cord paralysis analyzed in terms of the effective size of the functional subunit. Phys Med Biol (2008) 0.75
Secondary absorbed doses from light ion irradiation in anthropomorphic phantoms representing an adult male and a 10 year old child. Phys Med Biol (2010) 0.75
Cellular parameters and RBE-LET dependences for modelling heavy-ion radiotherapy. Radiother Oncol (2004) 0.75
Vascular structure and binomial statistics for response modeling in radiosurgery of cerebral arteriovenous malformations. Phys Med Biol (2010) 0.75
A Monte Carlo evaluation of carbon and lithium ions dose distributions in water. Int J Radiat Biol (2012) 0.75
Simulations of microdosimetric quantities with the Monte Carlo code FLUKA for carbon ions at therapeutic energies. Int J Radiat Biol (2011) 0.75
High brachytherapy doses can counteract hypoxia in cervical cancer-a modelling study. Phys Med Biol (2016) 0.75